Mrs. Lisa Diane Welch, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3100 Clay St, Paducah, KY 42001 Phone: 270-442-6884 |
Anthony Gallo Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 911 Joe Clifton Dr, Paducah, KY 42001 Phone: 270-709-2784 |
Wendell Wright, O.T. Occupational Therapist - Hand Medicare: Accepting Medicare Assignments Practice Location: 100 Clint Hill Blvd, Paducah, KY 42001 Phone: 270-442-9461 Fax: 270-441-0079 |
Kristina Lynn Kline, MOTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 100 Kiana Ct Suite A, Paducah, KY 42001 Phone: 270-443-0681 |
Kelly S Kirby, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2855 Jackson St, Paducah, KY 42003 Phone: 270-415-3618 Fax: 270-415-3601 |
News Archive
A connection between persistent insomnia and increased inflammation and mortality has been identified by a group of researchers from the University of Arizona. Their study, published in The American Journal of Medicine, found that people who suffer from persistent insomnia are at greater risk than those who experience intermittent insomnia.
Access to inpatient care for young people with mental health issues varies significantly across Europe, with mental health services providing up to fifty times more beds depending upon the country you live in.
A warning from Nigeria's National Emergency Management Agency about drought in northern parts of the country has raised "concern about food security not only in Africa's most populous nation but also in other parts of West Africa," Reuters AlertNet reports.
For baseball players with superior labral tears, conservative shoulder treatment may offer a better chance of returning to play than surgery, say US researchers.
Idera Pharmaceuticals, Inc. today announced that it has chosen to delay initiating its planned Phase 2 clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase 2 clinical trial involves the evaluation of IMO-2125 plus ribavirin in treatment-naïve, genotype 1 hepatitis C virus (HCV) patients.
› Verified 7 days ago